Materials • Major Chemicals
$38.86 ▲ +0.10
(+0.26%)
MKT CAP: $1.29B • VOL: 235.3K
52W L $31 52W H $53
ROARABLE / RQD
B- • 70/100
PIOTROSKI
6 / 9
REX // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-01-31 | FY 2023
FILED 2024-01-31 |
|---|---|---|---|
| Revenue (Total Sales) | $650.5M | $642.5M | $833.4M |
| YoY Revenue Growth % | +1.2% | -22.9% | — |
| Gross Profit | $125.4M | $91.5M | — |
| Gross Margin % | 19.3% | 14.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $0 | $0 | $0 |
| Operating Margin % | — | — | — |
| Net Income (GAAP) | $83.0M | $58.2M | $60.9M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $117.8M | $64.2M | $128.0M |
| Capital Expenditures (CapEx) | $68.4M | $71.3M | — |
| Free Cash Flow (FCF) | $49.4M | -$7.1M | $128.0M |
| FCF Margin % | 7.6% | -1.1% | 15.4% |
| Return on Invested Capital (ROIC %) | — | — | — |
| Cash & Short-Term Equivalents | $188.7M | $196.3M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $610.7M | $560.3M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR REX.